Research – R E C O R P U S

Throughout the history of human medicine, the developmental origin (genesis) or root cause of cancer has always been a mystery. Presently, several hypotheses regarding the origin of cancer prevail, including (i) the somatic mutation theory; (ii) the impaired energy metabolism theory; (iii) the cancer stem cell concept; (iv) the viral/microbial/fungal theory; (v) the tissue organization field theory; (vi) the bioelectric defect hypothesis, and numerous others. Upon closer examination, it becomes clear that all of these hypotheses have fundamental flaws or incorrect interpretations. While under specific circumstances, they do possess the potential to trigger the growth of cancer cells, they are not the real catalyst for cancer initiation and continued growth. Despite all the different explanations, the prevailing notion dictates that cancer arises from cells harboring specific molecular alterations or errors, such as mutations in particular genes. This widely accepted erroneous explanation has become deeply entrenched within the realms of science, medicine, and clinical practice.

Consequently, the broader landscape of research and treatment has primarily emphasized addressing the consequences or symptoms of cancer, such as cell proliferation, metabolic changes, metastasis, vascular responses, endocrine alterations, and immune reactions. The focus has traditionally been on managing these aspects rather than directly targeting the underlying origin of cancer growth. As a result, the majority of medical therapies available today, including clinical treatments, complementary approaches, and experimental interventions, have centered around eradicating cancer cells rather than eliminating the fundamental process that drives cancer growth.

Through an in-depth study of cancer and disease in different species including humans, I have come to a distinct and innovative understanding of cancer. Based on extensive observations and experimental evidence, my analyzes indicate that cancer arises from a common mechanism responsible for initiating and promoting cancer growth. Consequently, I propose that a single therapeutic intervention with broad applicability can potentially be employed universally across all types of cancers.

The novel treatment strategy, directly addresses the biophysical process that initiates and maintains cancer growth, distinguishing itself from existing therapies that primarily target the consequences or symptoms of cancer. By specific interventions of selected organs, the treatment renders cancer unnecessary and facilitates its disappearance. The new approach achieves this without the need for surgery, radiation or chemotherapy. Throughout my research, compelling evidence has emerged, indicating that this vision of restoring organs to their default healthy state is indeed feasible.

The effectiveness of the proposed treatment can be verified through a proof of concept (PoC) study conducted in a pre-clinical setting. However, a clinical trial can be directly initiated involving a small group of patients diagnosed with, for instance, liver or pancreas cancer. This trial can be successfully completed within 1 year, providing initial validation for the proposed treatment. It would employ specific chemotherapeutic agents with or without a readily available technology or surgery, for a gradual or more rapid response, respectively, in accordance with the newly proposed treatment strategy, to eliminate the underlying cause of cancer. This method would ensure a non-invasive and pain-free procedure, while offering a predicted improvement compared to current clinical treatments. Patients who are willing to participate in the treatment should ideally do so before surgery (or any other treatment), and follow the prescribed protocol for at least 6 weeks. Successful regression of tumor size within this timeframe would pave the way for implementing the new treatment strategy in patients with cancers in other organs. This expanded evaluation is estimated to require a total duration of approximately 2 years. I am 100% convinced that the newly discovered treatment strategy behind the PoC proposal should work and could potentially revolutionize healthcare in the near future.

RECORPUS proposed treatment is suitable for individuals of all age groups, ranging from the very young to the elderly. However, it is essential to recognize that the effectiveness of the treatment may vary among cancer patients, especially in older adults who have maintained an unhealthy lifestyle over an extended period of time or those with significant comorbidities. Many of their long-standing health issues have become deeply ingrained in their bodies over the course of several years, making it challenging to reverse them within the desired short timeframe typically expected in cancer treatment. Nevertheless, RECORPUS research indicates that the proposed treatment strategy would be able to treat cancer at any stage, including the currently untreatable advanced cancer stages such as pancreas or ovarian metastases. This proposed treatment also offers promising prospects for patients struggling with various metabolic disorders, infectious diseases, or specific aspects of aging.